Form 4 for MLAB MESA LABORATORIES INC /CO/
Accepted 2025-03-24 00:00:00 ET · period of report 2025-03-19 · accession 0001228924-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-24 | 2025-03-19 | MLAB | Owens Gary M | Pres, CEO | M - OptEx | $122.98 | +21.0K | 64.3K | +48% | +$2.58M |
| D | 2025-03-24 | 2025-03-19 | MLAB | Owens Gary M | Pres, CEO | S - Sale+OE | $123.91 | -21.0K | 43.3K | -33% | -$2.60M |
| D | 2025-03-24 | 2025-03-19 | MLAB | Owens Gary M | Pres, CEO | X - OptEx | $0.00 | -21.0K | 73.8K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-19 | M | A | 21,000 | $122.98 | 64,337 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-19 | S | D | 21,000 | $123.91 | 43,337 | D | — | — | (F2) Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on September 12, 2024 |
| 3 | Derivative | Non qualified Stock Option | 2025-03-19 | X | D | 21,000 | $0.00 | 73,769 | D | $122.98 · 2018-03-20 to 2025-03-20 | 21,000 Common Stock | (F1) 1/7 exercisable on each anniversary date of the 03/20/2017 grant date |